This project will investigate how intracellular signaling networks can be mapped and exploited to design more selective and context-dependent drugs. The goal is to identify underexplored or combinatorial pathway targets that can be modulated to increase specificity and reduce side effects. This will involve analysing recent advances in receptor crosstalk, feedback loops, and protein-protein interactions, possibly incorporating modeling or pathway databases.

Targeted therapies are critical for cost-effective R&D and market differentiation. By exploring smarter signaling-based designs, this project can suggest new angles for discovery teams or repositioning strategies. It also supports biomarker development and patient stratification.

I’m fascinated by systems biology and the precision potential in cell signaling logic. This project brings together basic science and translational potential — exactly what I want to specialise in during my Master’s in Pharmatechnology.

I have a genuine drive to understand biological systems in depth and turn that knowledge into meaningful innovation. I bring a mix of scientific rigor and creativity, and I approach problems with both analytical discipline and an open mind. I’m not afraid to think boldly and back it up with science.